In the risk category we constructed, patients with PI-RADS v2.1 score of ≤2, or PI-RADS v2.1 score of 3 and PSA density of <0.15 ng/mL2, could avoid unnecessary prostate biopsy without missing clinically significant prostate cancer. Here, KLK3 is linked to prostate carcinoma.